Author

Peter A. Revill

The Royal Melbourne HospitalORCID 0000-0003-2715-2541Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Joseph A. TrapaniiD· 1 shared Laura C. McCoulloughiD· 1 shared Mai Anh Thu Le· 1 shared Margaret LittlejohniD· 1 shared Mohamed FarehiD· 1 shared Yi Wen Liaw· 1 shared Zak T. JanetzkiiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Joseph A. TrapaniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintJul 17, 2026

Addressing viral genomic variability towards developing a Cas13b-based therapy

Mai Anh Thu Le, Laura C. McCoullough, Zak T. Janetzki…·Margaret Littlejohn

This study evaluates how viral genomic variability affects CRISPR-Cas13b efficacy against hepatitis B virus, showing that mismatched guide RNAs reduce antiviral activity and that sequence specificity is not the sole determinant of efficacy.

DOI 10.64898/2026.07.16.739033

humanCRISPR screen

𝕏 PostBluesky